Cargando…
Non-invasive diagnosis strategy of hepatocellular carcinoma in low-risk population
AIMS: With prevalence of hepatocellular carcinoma (HCC) in low-risk population (LRP), establishing a non-invasive diagnostic strategy becomes increasingly urgent to spare unnecessary biopsies in this population. The purposes of this study were to find characterisics of HCC and to establish a proper...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9238050/ https://www.ncbi.nlm.nih.gov/pubmed/35761201 http://dx.doi.org/10.1186/s12885-022-09812-w |
_version_ | 1784736941242056704 |
---|---|
author | Xie, Zonglin Peng, Zhenpeng Zou, Yujian Xiao, Han Li, Bin Zhou, Qian Chen, Shuling Xu, Lixia Shen, Jingxian Mo, Yunxian Peng, Sui Kuang, Ming Long, Jianting Feng, Shi-Ting |
author_facet | Xie, Zonglin Peng, Zhenpeng Zou, Yujian Xiao, Han Li, Bin Zhou, Qian Chen, Shuling Xu, Lixia Shen, Jingxian Mo, Yunxian Peng, Sui Kuang, Ming Long, Jianting Feng, Shi-Ting |
author_sort | Xie, Zonglin |
collection | PubMed |
description | AIMS: With prevalence of hepatocellular carcinoma (HCC) in low-risk population (LRP), establishing a non-invasive diagnostic strategy becomes increasingly urgent to spare unnecessary biopsies in this population. The purposes of this study were to find characterisics of HCC and to establish a proper non-invasive method to diagnose HCC in LRP. METHODS: A total of 681 patients in LRP (defined as the population without cirrhosis, chronic HBV infection or HCC history) were collected from 2 institutions. The images of computed tomography (CT) and magnetic resonance imaging (MRI) were manually analysed. We divided the patients into the training cohort (n = 324) and the internal validating cohort (n = 139) by admission time in the first institution. The cohort in the second institution was viewed as the external validation (n = 218). A multivariate logistic regression model incorporating both imaging and clinical independent risk predictors was developed. C-statistics was used to evaluate the diagnostic performance. RESULTS: Besides the major imaging features of HCC (non-rim enhancement, washout and enhancing capsule), tumor necrosis or severe ischemia (TNSI) on imaging and two clinical characteristics (gender and alpha fetoprotein) were also independently associated with HCC diagnosis (all P < 0.01). A clinical model (including 3 major features, TNSI, gender and AFP) was built to diagnose HCC and achieved good diagnostic performance (area under curve values were 0.954 in the training cohort, 0.931 in the internal validation cohort and 0.902 in the external cohort). CONCLUSIONS: The clinical model in this study developed a satisfied non-invasive diagnostic performance for HCC in LRP. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-022-09812-w. |
format | Online Article Text |
id | pubmed-9238050 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-92380502022-06-29 Non-invasive diagnosis strategy of hepatocellular carcinoma in low-risk population Xie, Zonglin Peng, Zhenpeng Zou, Yujian Xiao, Han Li, Bin Zhou, Qian Chen, Shuling Xu, Lixia Shen, Jingxian Mo, Yunxian Peng, Sui Kuang, Ming Long, Jianting Feng, Shi-Ting BMC Cancer Research AIMS: With prevalence of hepatocellular carcinoma (HCC) in low-risk population (LRP), establishing a non-invasive diagnostic strategy becomes increasingly urgent to spare unnecessary biopsies in this population. The purposes of this study were to find characterisics of HCC and to establish a proper non-invasive method to diagnose HCC in LRP. METHODS: A total of 681 patients in LRP (defined as the population without cirrhosis, chronic HBV infection or HCC history) were collected from 2 institutions. The images of computed tomography (CT) and magnetic resonance imaging (MRI) were manually analysed. We divided the patients into the training cohort (n = 324) and the internal validating cohort (n = 139) by admission time in the first institution. The cohort in the second institution was viewed as the external validation (n = 218). A multivariate logistic regression model incorporating both imaging and clinical independent risk predictors was developed. C-statistics was used to evaluate the diagnostic performance. RESULTS: Besides the major imaging features of HCC (non-rim enhancement, washout and enhancing capsule), tumor necrosis or severe ischemia (TNSI) on imaging and two clinical characteristics (gender and alpha fetoprotein) were also independently associated with HCC diagnosis (all P < 0.01). A clinical model (including 3 major features, TNSI, gender and AFP) was built to diagnose HCC and achieved good diagnostic performance (area under curve values were 0.954 in the training cohort, 0.931 in the internal validation cohort and 0.902 in the external cohort). CONCLUSIONS: The clinical model in this study developed a satisfied non-invasive diagnostic performance for HCC in LRP. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-022-09812-w. BioMed Central 2022-06-28 /pmc/articles/PMC9238050/ /pubmed/35761201 http://dx.doi.org/10.1186/s12885-022-09812-w Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Xie, Zonglin Peng, Zhenpeng Zou, Yujian Xiao, Han Li, Bin Zhou, Qian Chen, Shuling Xu, Lixia Shen, Jingxian Mo, Yunxian Peng, Sui Kuang, Ming Long, Jianting Feng, Shi-Ting Non-invasive diagnosis strategy of hepatocellular carcinoma in low-risk population |
title | Non-invasive diagnosis strategy of hepatocellular carcinoma in low-risk population |
title_full | Non-invasive diagnosis strategy of hepatocellular carcinoma in low-risk population |
title_fullStr | Non-invasive diagnosis strategy of hepatocellular carcinoma in low-risk population |
title_full_unstemmed | Non-invasive diagnosis strategy of hepatocellular carcinoma in low-risk population |
title_short | Non-invasive diagnosis strategy of hepatocellular carcinoma in low-risk population |
title_sort | non-invasive diagnosis strategy of hepatocellular carcinoma in low-risk population |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9238050/ https://www.ncbi.nlm.nih.gov/pubmed/35761201 http://dx.doi.org/10.1186/s12885-022-09812-w |
work_keys_str_mv | AT xiezonglin noninvasivediagnosisstrategyofhepatocellularcarcinomainlowriskpopulation AT pengzhenpeng noninvasivediagnosisstrategyofhepatocellularcarcinomainlowriskpopulation AT zouyujian noninvasivediagnosisstrategyofhepatocellularcarcinomainlowriskpopulation AT xiaohan noninvasivediagnosisstrategyofhepatocellularcarcinomainlowriskpopulation AT libin noninvasivediagnosisstrategyofhepatocellularcarcinomainlowriskpopulation AT zhouqian noninvasivediagnosisstrategyofhepatocellularcarcinomainlowriskpopulation AT chenshuling noninvasivediagnosisstrategyofhepatocellularcarcinomainlowriskpopulation AT xulixia noninvasivediagnosisstrategyofhepatocellularcarcinomainlowriskpopulation AT shenjingxian noninvasivediagnosisstrategyofhepatocellularcarcinomainlowriskpopulation AT moyunxian noninvasivediagnosisstrategyofhepatocellularcarcinomainlowriskpopulation AT pengsui noninvasivediagnosisstrategyofhepatocellularcarcinomainlowriskpopulation AT kuangming noninvasivediagnosisstrategyofhepatocellularcarcinomainlowriskpopulation AT longjianting noninvasivediagnosisstrategyofhepatocellularcarcinomainlowriskpopulation AT fengshiting noninvasivediagnosisstrategyofhepatocellularcarcinomainlowriskpopulation |